End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
8.92
CNY
|
+3.72%
|
|
+4.69%
|
-28.41%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,157
|
3,190
|
11,588
|
17,857
|
13,082
|
5,041
|
5,041
|
-
|
Enterprise Value (EV)
1 |
2,157
|
3,190
|
11,588
|
17,857
|
13,082
|
5,041
|
5,041
|
5,041
|
P/E ratio
|
26.5
x
|
25.1
x
|
50.2
x
|
50.7
x
|
16.3
x
|
-4.31
x
|
11.2
x
|
5.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
2.24%
|
5.83%
|
Capitalization / Revenue
|
1.44
x
|
-
|
6.05
x
|
4.41
x
|
0.93
x
|
0.32
x
|
0.26
x
|
0.21
x
|
EV / Revenue
|
1.44
x
|
-
|
6.05
x
|
4.41
x
|
0.93
x
|
0.32
x
|
0.26
x
|
0.21
x
|
EV / EBITDA
|
-
|
-
|
35
x
|
29.4
x
|
9.13
x
|
-6.4
x
|
4.6
x
|
2.87
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
6.02
x
|
8.04
x
|
2.77
x
|
1.42
x
|
1.26
x
|
1.03
x
|
Nbr of stocks (in thousands)
|
426,828
|
423,658
|
482,116
|
482,091
|
565,079
|
565,079
|
565,079
|
-
|
Reference price
2 |
5.054
|
7.529
|
24.04
|
37.04
|
23.15
|
8.920
|
8.920
|
8.920
|
Announcement Date
|
4/19/19
|
4/29/20
|
3/26/21
|
4/8/22
|
4/26/23
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,498
|
-
|
1,915
|
4,054
|
14,072
|
15,571
|
19,225
|
23,757
|
EBITDA
1 |
-
|
-
|
331.3
|
606.9
|
1,432
|
-788
|
1,096
|
1,757
|
EBIT
1 |
-
|
-
|
272.1
|
506.4
|
1,158
|
-1,035
|
922
|
1,622
|
Operating Margin
|
-
|
-
|
14.21%
|
12.49%
|
8.23%
|
-6.65%
|
4.8%
|
6.83%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
273.3
|
506.5
|
1,161
|
-1,035
|
922
|
1,622
|
Net income
1 |
-
|
127.4
|
202.8
|
350.8
|
752.9
|
-1,168
|
452
|
987
|
Net margin
|
-
|
-
|
10.59%
|
8.66%
|
5.35%
|
-7.5%
|
2.35%
|
4.15%
|
EPS
2 |
0.1905
|
0.3000
|
0.4786
|
0.7300
|
1.420
|
-2.070
|
0.8000
|
1.750
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
0.2000
|
0.5200
|
Announcement Date
|
4/19/19
|
4/29/20
|
3/26/21
|
4/8/22
|
4/26/23
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
14.2%
|
17.1%
|
21.1%
|
-28.2%
|
12%
|
22.2%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
7.91%
|
7.74%
|
7.24%
|
-7.5%
|
2.6%
|
4.8%
|
Assets
1 |
-
|
-
|
2,563
|
4,531
|
10,398
|
15,573
|
17,385
|
20,562
|
Book Value Per Share
2 |
-
|
-
|
3.990
|
4.610
|
8.360
|
6.290
|
7.090
|
8.640
|
Cash Flow per Share
2 |
-
|
-
|
0.6300
|
-0.8500
|
-5.750
|
1.490
|
1.230
|
2.140
|
Capex
1 |
-
|
-
|
248
|
509
|
1,116
|
360
|
360
|
460
|
Capex / Sales
|
-
|
-
|
12.94%
|
12.56%
|
7.93%
|
2.31%
|
1.87%
|
1.94%
|
Announcement Date
|
4/19/19
|
4/29/20
|
3/26/21
|
4/8/22
|
4/26/23
|
-
|
-
|
-
|
Last Close Price
8.92
CNY Average target price
14.49
CNY Spread / Average Target +62.44% Consensus |
1st Jan change
|
Capi.
|
---|
| -28.41% | 696M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|